Pediatric Endocrinology and Diabetes Unit, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Diabetes Metab Res Rev. 2021 Jan;37(1):e3356. doi: 10.1002/dmrr.3356. Epub 2020 Jun 21.
Younger age at diagnosis of type 1 diabetes (T1D) may affect the clinical course and outcome. We examined whether age at diagnosis was associated with glycemic control and metabolic outcome in young adulthood.
This observational study included 105 young adults with T1D (current mean age: 21.2 ± 3.0 years, mean age at diagnosis 12.0 ± 4.0 years) followed during 2012 to 2019. Data on HbA1c, glucose variability, continuous glucose monitoring (CGM) metrics, body mass index (BMI), blood pressure (BP), and body composition were collected from medical records from age 18 years until last visit, and the association between age at diagnosis and outcomes was assessed.
Age at T1D diagnosis was negatively associated with HbA1c levels (r = -0.368, P = .001), BMI (r = -0.218, P = .026), and diastolic BP (r = -0.215, P = .028). Younger age at diagnosis predicted poorer glycemic control after controlling for T1D duration, sex, socioeconomic status, BMI, and CGM use (r = 0.19, P = .002). There was a 0.1% greater HbA1c reduction for every yearly increase in age at diagnosis (β = -0.090, P = .042). The mean metabolic age of females diagnosed at <10 years of age was older than their chronological age (P = .049).
Younger age at T1D diagnosis predicts worse glycemic control at young adulthood, independent of recognized confounding risk factors (disease duration, sex, socioeconomic status, weight, and use of diabetes technology). Female patients diagnosed at a young age have an older metabolic age, indicating the need for lifestyle alteration to improve their basal metabolic rate.
1 型糖尿病(T1D)的发病年龄可能会影响临床病程和结局。我们研究了在成年早期,发病年龄是否与血糖控制和代谢结局相关。
这项观察性研究纳入了 105 名 T1D 年轻患者(当前平均年龄 21.2±3.0 岁,平均发病年龄 12.0±4.0 岁),随访时间为 2012 年至 2019 年。18 岁以后,从病历中收集了糖化血红蛋白(HbA1c)、血糖变异性、连续血糖监测(CGM)指标、体重指数(BMI)、血压(BP)和身体成分等数据,直至最后一次就诊,评估了发病年龄与结局的关系。
T1D 发病年龄与 HbA1c 水平(r=-0.368,P=.001)、BMI(r=-0.218,P=.026)和舒张压(r=-0.215,P=.028)呈负相关。在校正 T1D 病程、性别、社会经济地位、BMI 和 CGM 使用后,发病年龄越小,血糖控制越差(r=0.19,P=.002)。每增加 1 岁,HbA1c 降低 0.1%(β=-0.090,P=.042)。发病年龄<10 岁的女性患者的代谢年龄比实际年龄大(P=.049)。
T1D 发病年龄越小,成年早期血糖控制越差,独立于已知的混杂危险因素(病程、性别、社会经济地位、体重和糖尿病技术的使用)。发病年龄较小的女性患者代谢年龄较大,表明需要改变生活方式以提高基础代谢率。